Rx-to-OTC switches: From prescription to self-care

Journal of the American Pharmaceutical Association

Volumn 36, Issue 8, 1996, Pages

  Newton, G ^a   Popovich, N G ^a   Pray, W S ^a  

^a DUQUESNE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

DRUG CHOICE; HUMAN; PATIENT COUNSELING; PHARMACIST; PRESCRIPTION; REVIEW; SELF CARE; SELF MEDICATION; ARTICLE; PATIENT EDUCATION;

DRUGS, NON-PRESCRIPTION; HUMANS; PATIENT EDUCATION; PHARMACISTS; SELF MEDICATION;

EID: 0029768859     PISSN: 10865802     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1086-5802(16)30103-6     Document Type: Review

References (30)

1. E.E. Bachrach The FDA's new over-the-counter drug office and advisory committee: An industry perspective Food & Drug Law J. 48 1993 563 566
2. M. Segal Rx to OTC—The switch is on FDA Consumer. 25 2 1991 9 11
3. G.M. Rachanow The switch of drugs from prescription to over-the-counter status Food Drug & Cosmetic Law J. 39 1984 201 210
4. P.H. Rheinstein Criteria used by the FDA to determine what classes of drugs are appropriate switch candidates Drug Information J. 19 1985 139 142
5. P.B. Hutt A legal framework for future decisions on transferring drugs from prescription to nonprescription status Food Drug Cosmetic Law J. 37 1982 427 440
6. M. Smith Rx to OTC: Boon or boondoggle? Drug Topics. 136 7 1992 96 103
7. A.A. Barnett OTC status denied to cholestyramine Pharmacy Today. 1 16 1995 14
8. Topical erythromycin OTC switch rejected Weekly Pharmacy Reports. 43 48 1994 3 9
9. FDA hears case for acyclovir switch NDMA Special Report 1994 1 2 May 20
10. A.H. Kaplan Over-the-counter and prescription drugs: the legal distinction under federal law Food Drug Cosmetic Law J. 37 1982 441 445
11. K. Snyder Hair today and tomorrow Drug Topics. 139 23 1995 72
12. W.D. Appler Home-use AIDS tests: FDA's dilemma Medical Device & Diagnostic Industry. 11 6 1989 37
13. D.C. McLeod Nonprescription drug approval: therapeutic strategy or marketing decision? DICP, Ann Pharmacother. 23 1989 606 609
14. M. Novitch Trends driving the over-the-counter drug market Drug Information J. 25 1991 445 448
15. J.D. Cope Self-care/self-medication: where are we headed? Drug Information J. 25 1991 595 598
16. Handbook of Nonprescription Drugs 10th ed. 1993 American Pharmaceutical Association Washington DC 4 7
17. R.W. Soller Outlook for OTC switches American Pharm. NS31 2 1991 38 40
18. Health Care Practices and Perceptions—A Consumer Survey of Self-Medication. Pub. HHR-72792 1984 Harry Heller Research Corp Washington DC Feb
19. P. Temin Cost benefits in switching drugs from Rx to OTC J. Health Econ. 2 1983 187 205
20. G.W. Lawless Vice President of Medical and Pharmacy Affairs/Corporate Medical Director, Blue Cross of Western Pennsylvania 1995 Personal communication Pittsburgh, Pa
21. 1995 Drug Topics Redbook 1995 Medical Economics Montvale, NJ
22. G. Muirhead Coverage for OTCs? Drug Topics 139 16 1995 38
23. M.F. Conlan FDA may move to allow sale of drugs as both Rx and OTC Drug Topics. 133 22 1989 51
24. Double trouble? Drug Topics. 133 11 1989 5
25. C. Holt Antagonists spar for OTC championship American Druggist. 212 8 1995 32 36
26. Heartburn judgment Drug Topics. 139 21 1995 30
27. Manufacturers are urged to switch Rxs to OTC American Druggist. 195 2 1987 32,34
28. D.M. Vickery A medical perspective Drug Information J. 9 1985 155 158
29. D.H. Murphy Taking chance out of the Rx-OTC switch American Pharm. NS25 1 1985 41 45
30. L. Hendeles Weinberger Nonprescription sales of inhaled metaproterenol—déjà vu N Engl J Med. 310 1984 207 208